NCT00270686

Brief Summary

Background: \- Heritable disorders of connective tissue are genetic conditions that can affect the skin and other parts of the body. They are related to mutations in genes that are responsible for building tissues. The symptoms differ among disorders. Researchers want to study which genes may be responsible for different disorders. They will be performing a long-term (up to 10 years) study and a study that requires a single visit. These studies will look at how these disorders affect the body and what genes may cause these conditions. Objectives: \- To perform one-time and long-term studies of people who have heritable disorders of connective tissue. Eligibility: \- Individuals at least 2 years of age who have or may have a heritable disorder of connective tissue. Design:

  • Participants will be screened with a physical exam, medical history, and blood samples.
  • Participants will be on one of two parts of this study. The longitudinal arm will require long-term study over about 10 years. The mutational analysis arm will involve a single visit.
  • Longitudinal arm participants must be at least 12 years of age. They will have study visits at regular intervals for up to 10 years. The tests given at these visits may include all or some of the following:
  • Blood, saliva, urine, and skin samples
  • Heart and lung function tests
  • Magnetic resonance imaging scans of the neck, chest, spine, and abdomen
  • Other imaging studies such as x-rays, bone density scans, and ultrasounds
  • Questionnaires about sleep, pain, and quality of life
  • Photographs of affected areas.
  • Mutational analysis arm participants will have a single study visit. They will provide blood and saliva samples. They will provide tissue from a skin biopsy. They will also let the researchers take photos of any affected body parts. They will complete questionnaires about sleep, pain, and quality of life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
929

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2003

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 21, 2003

Completed
2.9 years until next milestone

First Submitted

Initial submission to the registry

December 27, 2005

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 28, 2005

Completed
9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 2, 2015

Completed
Last Updated

April 5, 2018

Status Verified

January 2, 2015

First QC Date

December 27, 2005

Last Update Submit

April 4, 2018

Conditions

Keywords

Ehlers-Danlos SyndromeStickler SyndromeMarfan SyndromeGeneticsAneurysm

Outcome Measures

Primary Outcomes (4)

  • Description of natural history of Hereditary Disorders of Connective Tissue (HDCT)

    Ongoing

  • Genetic analysis to identify novel genes that cause HDCT

    Ongoing

  • Biochemical analysis of biospecimens to identify correlations with disease activity and progress

    Ongoing

  • Identification of disease treatment targets

    Ongoing

Eligibility Criteria

Age2 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals and their family members will be offered enrollment if they have an established or suspected diagnosis of Marfan, Stickler, or Ehlers-Danlos syndrome, or Overlap connective tissue disorder.
  • Determination of eligibility will be made by review of prior records.
  • In some cases, a screening evaluation to establish the diagnosis may be performed subjects may be excluded from further participation if the diagnosis is ruled out. Cytogenetic analysis may be necessary to rule out a chromosomal abnormality that has overlapping features with HDCT.

You may not qualify if:

  • Pregnant and nursing women may be limited in their participation in some aspects of the study (e.g. ionizing radiation exposure or MRI) during the time that they are pregnant or nursing.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institute of Aging, Clinical Research Unit

Baltimore, Maryland, 21224, United States

Location

Related Publications (3)

  • Ainsworth SR, Aulicino PL. A survey of patients with Ehlers-Danlos syndrome. Clin Orthop Relat Res. 1993 Jan;(286):250-6.

    PMID: 8425354BACKGROUND
  • Beighton P, de Paepe A, Danks D, Finidori G, Gedde-Dahl T, Goodman R, Hall JG, Hollister DW, Horton W, McKusick VA, et al. International Nosology of Heritable Disorders of Connective Tissue, Berlin, 1986. Am J Med Genet. 1988 Mar;29(3):581-94. doi: 10.1002/ajmg.1320290316. No abstract available.

    PMID: 3287925BACKGROUND
  • Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213. doi: 10.1016/0165-1781(89)90047-4.

    PMID: 2748771BACKGROUND

MeSH Terms

Conditions

Ehlers-Danlos SyndromeStickler syndrome, type 1Marfan SyndromeAneurysm

Condition Hierarchy (Ancestors)

Hemostatic DisordersVascular DiseasesCardiovascular DiseasesHemorrhagic DisordersHematologic DiseasesHemic and Lymphatic DiseasesSkin AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSkin Diseases, GeneticGenetic Diseases, InbornCollagen DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesSkin DiseasesBone Diseases, DevelopmentalBone DiseasesMusculoskeletal DiseasesHeart Defects, CongenitalCardiovascular AbnormalitiesHeart DiseasesAbnormalities, Multiple

Study Officials

  • Nazli B McDonnell, M.D.

    National Institute on Aging (NIA)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 27, 2005

First Posted

December 28, 2005

Study Start

January 21, 2003

Study Completion

January 2, 2015

Last Updated

April 5, 2018

Record last verified: 2015-01-02

Locations